Since Helicobacter pylori was first isolated from human gastric biopsy material in 1982,1 the gold standard diagnostic test has remained histological analysis and culture of antral biopsy specimens.2 These techniques are invasive and may take 24-72 hours, and therefore there is a need for a good serological test that would avoid the need for endoscopy. The systemic hormonal antibody response to H pylon is well documented and correlates well with infection.35 Enzyme linked immunosorbent assay (ELISA) has been used widely in epidemiological studies and more recently for monitoring the longterm outcome of H pylon therapeutic regimens. 6 Sobala's proposal to perform H pylori serology on all patients under 45 years referred for endoscopy reduced workload by 30%.7 Workload could be reduced further by raising the cut oif to 55 years without reducing the detection of malignant disease.8
Dyspeptic patients who purchase over the counter H2 antagonists may benefit from H pylon eradication rather than repeat self treatment with cimetidine. A simple serological test to assess their H pylori status would therefore be very useful to general practitioners.
We evaluated a new saliva test for the diagnosis of H pylori, comparing this with gold standard evidence of H pylon and also with a serum serological test. The Cortecs Diagnostics Helisal Assay is a quantitative immunoassay for the measurement of salivary IgG antibodies against H pylori. Saliva collection has the advantage of being a non-invasive simple test that can be easily performed in the general practice setting; collection is easy for patients and health care personnel and greatly reduces the risk of bloodborne infections.
Methods
Eighty six unselected patients undergoing endoscopy at Gloucestershire Royal Hospital for investigation of dyspepsia took part. Blood and saliva were taken prior to endoscopy. At endoscopy, three antral biopsy specimens were taken for urease test, culture, and histology.9 If any one of these 'gold standard' tests were positive, the patients were deemed H pylori positive. The predictive value of the saliva test was compared with these gold standard tests, as well as a serum serological test.
The saliva was collected using an Omni-Sal collection device; this resembles an absorbent lollipop. The device is placed in the mouth for approximately 2-5 minutes. When enough saliva has been produced, the tip of the device turns from white to blue. The device is then placed into a separator tube containing buffer, and can be stored at room temperature for up to one month. All sera were stored in aliquots at -20°C until assayed.
Plastic microwells coated with antigens extracted from H pylori were incubated with control/standard solutions and the samples of human saliva for 30 minutes. Salivary (IgG) antibodies to H pylori present in the samples become bound to antigen on the microwells. Results or histology. In the H pylori positive group, there were four patients with duodenal ulceration and one case of gastric ulceration. There was one case of superficial duodenal ulceration and no cases of gastric ulceration in the H pylori negative group.
In the group of 86 patients, not all gave both blood and saliva and therefore, in the analysis there is a small discrepancy in the total number of salivary tests compared with serum tests.
The mean (SD) salivary IgG titre for H pylori positive and negative patients was 1.16 (1.46) and 0'171 (0.251) respectively. These results are significantly different with p value of le'ss than 0.005. The mean (SD) serum IgG titre for H pylori positive and negative patients was 5.02 (4.03) and 0-68 (092) respectively, which is also significantly different (p>0O005). Figure 1 shows the EU values for the saliva samples. The Table shows been inadvertent) may remain antibody positive but be biopsy negative for H pylori for at least six months after treatment.'0 Reviewing the hospital notes, five of the patients with false positive results had documented antimicrobials active against Hpylori prior to endoscopy. Fourthly, three of the patients with false positive results were receiving longterm omeprazole treatment, which can suppress the levels of H pylori and make detection more difficult. Our study was designed to assess the use of the saliva test in a district general endoscopy a service and there were no exclusion criteria for patients. Saliva has the advantage of being easier to collect and store, lending itself to widespread use in the community and in epidemiological studies. It would be useful for studies in children where screening with serum would be more difficult. Unlike serum, which needs to be separated within a few hours from blood cells, saliva samples could be collected and posted and batched for up to a month before testing.
The sensitivity of this saliva test is the same as that recently described by Patel.16 However, the prevalence of H pylori in their study was 50%, near to the optimum for both tests. Our study was undertaken in an endoscopy population in which the prevalence of H pylori was 40%. As the prevalence of H pylori would be expected to be lower in general practice than an endoscopy population the negative predictive value of the test in this setting should be higher making it a valuable screening test in this setting -but the positive predictive value would be much lower (Fig 3) . Although our test detected all patients with peptic ulceration we would still suggest that not only the test be modified to improve its specificity but that further work is done to evaluate its predictive value in general practice to determine the role of such a test in patient management and screening.
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